These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 26801478)

  • 1. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Hasegawa J; Sekine A; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):593-601. PubMed ID: 26801478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary RBP as an Independent Predictor of Renal Outcome in Diabetic Nephropathy.
    Cai F; Zhang L; Zhao P; Qiu F; Mukhtar AM; Ma Y; Chen J; Han F
    Dis Markers; 2022; 2022():9687868. PubMed ID: 36299825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.
    Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Kitagawa K; Shimizu M; Furuichi K; Wada T
    PLoS One; 2018; 13(1):e0190930. PubMed ID: 29338014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
    Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H
    Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
    Minakami H
    Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubular dysfunction in the early stage of diabetic nephropathy.
    Tanaka A; Shima K; Fukuda M; Tahara Y; Yamamoto Y; Kumahara Y
    Med J Osaka Univ; 1989 Mar; 38(1-4):57-63. PubMed ID: 2485397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
    Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW
    Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study.
    Navarro JF; Mora C; Muros M; Maca M; Garca J
    Am J Kidney Dis; 2003 Aug; 42(2):264-70. PubMed ID: 12900807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the interstitial fibrosis and tubular atrophy on the new pathological classification in patients with diabetic nephropathy: A single-center study in China.
    Zhu X; Xiong X; Yuan S; Xiao L; Fu X; Yang Y; Tang C; He L; Liu F; Sun L
    J Diabetes Complications; 2016 Apr; 30(3):537-41. PubMed ID: 26796433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Willems HL; Wetzels JF
    Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
    Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
    Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary protein markers predict the severity of renal histological lesions in children with mesangial proliferative glomerulonephritis.
    Li Y; Wang J; Zhu X; Feng Q; Li X; Feng X
    BMC Nephrol; 2012 May; 13():29. PubMed ID: 22607047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.
    Basturk T; Altuntaş Y; Kurklu A; Aydin L; Eren N; Unsal A
    Ren Fail; 2006; 28(2):125-8. PubMed ID: 16538969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease.
    Lee YH; Kim KP; Park SH; Kim DJ; Kim YG; Moon JY; Jung SW; Kim JS; Jeong KH; Lee SY; Yang DH; Lim SJ; Woo JT; Rhee SY; Chon S; Choi HY; Park HC; Jo YI; Yi JH; Han SW; Lee SH
    Nephrol Dial Transplant; 2021 Jan; 36(2):295-305. PubMed ID: 31598726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
    Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Novel Urinary Biomarkers for Predicting Renal Prognosis in Patients With Type 2 Diabetes by Glycan Profiling in a Multicenter Prospective Cohort Study: U-CARE Study 1.
    Mise K; Imamura M; Yamaguchi S; Teshigawara S; Tone A; Uchida HA; Eguchi J; Nakatsuka A; Ogawa D; Yoshida M; Yamada M; Shikata K; Wada J
    Diabetes Care; 2018 Aug; 41(8):1765-1775. PubMed ID: 29930140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
    Banu N; Hara H; Okamura M; Egusa G; Yamakido M
    Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus.
    Bouvet BR; Paparella CV; Arriaga SM; Monje AL; Amarilla AM; Almará AM
    Arq Bras Endocrinol Metabol; 2014 Nov; 58(8):798-801. PubMed ID: 25465599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.